Though new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.
Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Working for the USPHS offers unique compensation and quality-of-life benefits.
There are no clearly defined, widely accepted clinical pharmacist metrics.
Panelists discuss how factors such as patient preferences, disease severity, organ-specific involvement, and adverse effect profiles influence the selection of second-line therapies for steroid-refractory chronic graft-vs-host disease (cGVHD) in the context of multiple FDA-approved agents.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.
In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Gender-affirming care and inclusive practices are essential for health equity.
These facilities provide significant value to payers and patients.
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.
Advances, challenges, and promising innovations emerge.
This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
This interstate agreement can empower pharmacists to respond to large-scale emergencies
CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.
Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.
Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.
Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.
Even when safe, oral supplement use may not be appropriate to use during cancer treatment or recovery.
This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Fabry disease is a rare X-linked, lysosomal storage disorder that can cause renal failure or stroke.
Remote services allow unrivaled opportunities for outreach to vulnerable populations and those in rural areas.
Unlike conventional monoclonal antibodies, BsAbs possess dual binding domains that target 2 distinct antigens simultaneously.
Expert shares insights on leadership resilience, emphasizing self-awareness, team development, and maintaining personal worth beyond professional achievements.